Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |